Scarica l'app Stockscreener
0.99
10.81%
-0.12
Anebulo Pharmaceuticals Inc Azioni (ANEB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
39.71%
1.6643
|
2.7605 | 2.5437 | 2.4944 | 2.864 |
| Operating Income/Loss |
39.71%
-1.6643
|
-2.7605 | -2.5437 | -2.4944 | -2.864 |
| Nonoperating Income/Loss |
75.15%
0.0107
|
0.0431 | 0.0629 | - | - |
| Income/Loss From Continuing Operations Before Tax |
39.15%
-1.6535
|
-2.7174 | -2.4808 | -2.4956 | -2.798 |
| Income/Loss From Continuing Operations After Tax |
39.15%
-1.6535
|
-2.7174 | -2.4808 | -2.4956 | -2.798 |
|
Net Income/Loss
|
39.15%
-1.6535
|
-2.7174 | -2.4808 | -2.4956 | -2.798 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.56%
25.93
|
25.79 | 25.63 | 0.1856 | 25.63 |
| Diluted Average Shares |
0.56%
25.93
|
25.79 | 25.63 | - | - |
| Basic Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.10 | 0.84 | -0.11 |
| Diluted Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.10 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):